CIK 0001175151 · Non-accelerated filer<br>Smaller reporting company
Cytosorbents Corp
Sign in to watch- Ticker
- CTSO
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 980373793
- Phone
- 973-329-8885
- Business address
- 305 COLLEGE ROAD EAST, PRINCETON, NJ, 08540
- Former names
- MedaSorb Technologies CORP, GILDER ENTERPRISES INC
- Open-market buys, last 90 days
- $120,435
- in 4 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$120,435. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 63 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-10-04 | Deliargyris Efthymios Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2024-10-04 | Deliargyris Efthymios Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2024-10-04 | Capponi Vincent President and COO | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2024-10-04 | Capponi Vincent President and COO | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2024-08-14 | MARIANI PETER J Chief Financial Officer | Grant or award | +110,000 | 110,000 | ||
| 2024-08-14 | MARIANI PETER J Chief Financial Officer | Grant or award | +65,000 | 175,000 | ||
| 2024-08-14 | MARIANI PETER J Chief Financial Officer | Grant or award | +175,000 | 350,000 | ||
| 2024-08-14 | MARIANI PETER J Chief Financial Officer | Grant or award · Stock Option (right to buy) | +80,000 | 80,000 | ||
| 2024-08-14 | MARIANI PETER J Chief Financial Officer | Grant or award · Stock Option (right to buy) | +215,000 | 215,000 | ||
| 2024-04-02 | Jones Edward Raymond Director | Grant or award · Stock Option (Right to Buy) | +22,000 | 22,000 | ||
| 2024-04-02 | Deliargyris Efthymios Chief Medical Officer | Grant or award | +61,000 | 409,433 | ||
| 2024-04-02 | Deliargyris Efthymios Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +86,000 | 86,000 | ||
| 2024-04-02 | Sobel Alan D. Director | Grant or award · Stock Option (Right to Buy) | +22,000 | 22,000 | ||
| 2024-04-02 | BLOCH KATHLEEN P. Chief Financial Officer | Grant or award | +65,000 | 532,941 | ||
| 2024-04-02 | BLOCH KATHLEEN P. Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +87,000 | 87,000 | ||
| 2024-04-02 | BATOR MICHAEL G. Director | Grant or award · Stock Option (Right to Buy) | +44,000 | 44,000 | ||
| 2024-04-02 | Capponi Vincent President and COO | Grant or award | +81,000 | 665,134 | ||
| 2024-04-02 | Capponi Vincent President and COO | Grant or award · Stock Option (Right to Buy) | +101,000 | 101,000 | ||
| 2024-04-02 | Kim Jiny Director | Grant or award · Stock Option (Right to Buy) | +22,000 | 22,000 | ||
| 2024-04-02 | Chan Phillip P. Chief Executive Officer | Grant or award | +96,000 | 1,164,704 |
Page 4 of 35 · 698 trades